MGI Platform Contributes to the COVID-19 Efforts in 23 Provinces in China
In response to the COVID-19 resurgence in Nanjing, Changsha, Beijing, Anhui, Sichuan, Hainan, and Fujian, MGI quickly deployed its mobile nucleic acid testing platforms to help local health authoritie...
More2021-08-03